Abstract
Purpose
To investigate whether cardiovascular drug classes and specific beta-blockers are associated with antidepressant drug use in a large study population of older people.
Methods
We analyzed data from the Swedish Prescribed Drug Register from October-December 2005 for people aged 75 years and older (n = 732,230). Logistic regression analysis was used to study the association between the cardiovascular drugs and antidepressants, after adjustment for age, sex, and number of other dispensed drugs.
Results
All the cardiovascular drug classes were negatively or not associated with use of any antidepressant, non-selective monoamine reuptake inhibitors, and SSRIs, after adjustment for age, sex, and number of other dispensed drugs. However, propranolol was associated with an increased use of any antidepressant, non-selective monoamine reuptake inhibitors, and SSRIs, after adjustment for age, sex, and number of other dispensed drugs. Atenolol was positively associated with non-selective monoamine reuptake inhibitors, although to a lesser extent than propranolol.
Conclusions
None of the cardiovascular drug classes were associated with increased antidepressant drug use, after adjustment for age, sex, and use of other drugs. However, when focusing specifically on beta-blockers, our results indicate that propranolol may be the beta-blocker most closely associated with use of antidepressants in the elderly.
Similar content being viewed by others
References
Agostini JV, Tinetti ME, Han L, Peduzzi P, Foody JM, Concato J (2007) Association between antihypertensive medication use and non-cardiovascular outcomes in older men. J Gen Intern Med 22:1661–1667
Hallas J (1996) Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Epidemiology 7:478–484
Kotlyar M, Dysken M, Adson DE (2005) Update on drug-induced depression in the elderly. Am J Geriatr Pharmacother 3:288–300
Patten SB, Barbui C (2004) Drug-induced depression: a systematic review to inform clinical practice. Psychother Psychosom 73:207–215
Okada F (1985) Depression after treatment with thiazide diuretics for hypertension. Am J Psychiatry 142:1101–1102
Schleifer SJ, Slater WR, Macari-Hinson MM et al (1991) Digitalis and beta-blocking agents: effects on depression following myocardial infarction. Am Heart J 121:1397–1402
Ried LD, Johnson RE, McFarland BH, Brody KK (2000) Antihypertensive drug use and the risk of depression among older hypertensives in an HMO. J Pharmacoepidemiol 8:1–28
Dunn NR, Freemantle SN, Mann RD (1999) Cohort study on calcium channel blockers, other cardiovascular agents, and the prevalence of depression. Br J Clin Pharmacol 48:230–233
Patten SB, Williams JV, Love EJ (1995) Self-reported depressive symptoms in association with medication exposures among medical inpatients: a cross-sectional study. Can J Psychiatry 40:264–269
Ko DT, Hebert PR, Coffey CS, Sedrakyan A, Curtis JP, Krumholz HM (2002) Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 288:351–357
Ried LD, McFarland BH, Johnson RE, Brody KK (1998) Beta-blockers and depression: the more the murkier? Ann Pharmacother 32:699–708
Steffensmeier JJ, Ernst ME, Kelly M, Hartz AJ (2006) Do randomized controlled trials always trump case reports? A second look at propranolol and depression. Pharmacotherapy 26:162–167
van Melle JP, Verbeek DE, van den Berg MP, Ormel J, van der Linde MR, de Jonge P (2006) Beta-blockers and depression after myocardial infarction: a multicenter prospective study. J Am Coll Cardiol 48:2209–2214
Johnson JA, Wallace SM (1997) Investigating the relationship between beta-blocker and antidepressant use through linkage of the administrative databases of Saskatchewan Health. Pharmacoepidemiol Drug Saf 6:1–11
Jyrkka J, Vartiainen L, Hartikainen S, Sulkava R, Enlund H (2006) Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+ Study. Eur J Clin Pharmacol 62:151–158
Silwer L, Lundborg CS, Petzold M (2008) Prevalence of purchase of antihypertensive and serum lipid-reducing drugs in Sweden–individual data from national registers. Pharmacoepidemiol Drug Saf 17:37–42
Wettermark B, Hammar N, Fored CM et al (2007) The new Swedish Prescribed Drug Register–opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 16:726–735
WHO Collaborating Centre for Drug Statistics Methodology (2008) About the ATC/DDD system. http://www.whocc.no/atcddd/. Accessed 17 July 2008
Lau HS, de Boer A, Beuning KS, Porsius A (1997) Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol 50:619–625
Johnell K, Klarin I (2007) The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf 30:911–918
Patten SB, Esposito E, Carter B (2007) Reasons for antidepressant prescriptions in Canada. Pharmacoepidemiol Drug Saf 16:746–752
Salzman C (1999) Practical considerations for the treatment of depression in elderly and very elderly long-term care patients. J Clin Psychiatry 60 Suppl 20:30–33
The Swedish Medical Products Agency (2004) Pharmacotherapy in unipolar depression in adults and elderly - treatment guidelines (in Swedish). Information from the Swedish Medical Products Agency 5:2004
Rosholm JU, Andersen M, Gram LF (2001) Are there differences in the use of selective serotonin reuptake inhibitors and tricyclic antidepressants? A prescription database study. Eur J Clin Pharmacol 56:923–929
Hoffman BB (2007) Adrenoceptor antagonist drugs. In: Katzung BG (ed) Basic and clinical pharmacology, 10th ed. McGraw-Hill, New York
Benazon NR, Mamdani MM, Coyne JC (2005) Trends in the prescribing of antidepressants following acute myocardial infarction, 1993–2002. Psychosom Med 67:916–920
Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ (2001) Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 154:854–864
Bright RA, Everitt DE (1992) Beta-blockers and depression. Evidence against an association. JAMA 267:1783–1787
Statistics Sweden (2005) The population in Sweden according to sex and age 31/12/2005 (in Swedish). SCB, Stockholm
Johnell K, Fastbom J, Rosen M, Leimanis A (2007) Inappropriate drug use in the elderly: a nationwide register-based study. Ann Pharmacother 41:1243–1248
Haukka J, Suvisaari J, Tuulio-Henriksson A, Lonnqvist J (2007) High concordance between self-reported medication and official prescription database information. Eur J Clin Pharmacol 63:1069–1074
Poluzzi E, Strahinja P, Vargiu A et al (2005) Initial treatment of hypertension and adherence to therapy in general practice in Italy. Eur J Clin Pharmacol 61:603–609
Giron MS, Fastbom J, Winblad B (2005) Clinical trials of potential antidepressants: to what extent are the elderly represented: a review. Int J Geriatr Psychiatry 20:201–217
Van Spall HG, Toren A, Kiss A, Fowler RA (2007) Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 297:1233–1240
Acknowledgements
We thank the National Board of Health and Welfare for providing us the data. We also wish to thank Associate Professor Ingemar Kåreholt for statistical advice. This study was supported by grants from the Swedish Council for Working Life and Social Research and The Swedish Research Council.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Johnell, K., Fastbom, J. The association between use of cardiovascular drugs and antidepressants: a nationwide register-based study. Eur J Clin Pharmacol 64, 1119–1124 (2008). https://doi.org/10.1007/s00228-008-0541-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-008-0541-3